Snapshot Of Attending Companies:
3rd Targeted Protein Degradation Summit Returns this March!
Join this exclusive three-day forum to explore the selectivity, bioavailability, and pharmacokinetic profile of TPD to guarantee safety, efficacy, and potency.
This community will spend 3 days be uncovering computational modelling of TPD, improving predictions and understanding target selectivity, along with optimizing degrader design via novel platform strategies.
Don't miss this fantastic opportunity to gain invaluable insights from top biopharma industry leaders!
Snapshot of the 30+ TPD Speaker Faculty
Esther Fernandez Velando
Head Flexible Biology Platforms
Chief Scientific Officer
Vice President, Head of DMPK M&S
COLTAC Therapeutics / Tel Aviv University
Director - Cheminformatics & Machine Learning
Founder & Chief Executive Officer
Origami Therapeutics, Inc.
Boehringer Ingelheim RCV
Group Discounts Available
To ensure the 3rd TPD Europe conference is as valuable to you and your team as possible, the 2022 programme boasts 2 dedicated streams of presentations to cater to all areas of expertise in the TPD field!
Maximize your value for money using special team discounts:
10% discount - 3 delegates
15% discount - 4 delegates
20% discount - 5+ delegates